Published in PLoS Negl Trop Dis on August 17, 2010
Global health initiative investments and health systems strengthening: a content analysis of global fund investments. Global Health (2013) 1.60
Toward a consensus on guiding principles for health systems strengthening. PLoS Med (2010) 1.56
Diagnosis of neglected tropical diseases among patients with persistent digestive disorders (diarrhoea and/or abdominal pain ≥14 days): Pierrea multi-country, prospective, non-experimental case-control study. BMC Infect Dis (2015) 1.50
Neglected tropical diseases and the millennium development goals: why the "other diseases" matter: reality versus rhetoric. Parasit Vectors (2011) 1.45
Surgical Care and Health Systems. World J Surg (2015) 1.16
Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests. BMC Infect Dis (2013) 1.11
Implementing preventive chemotherapy through an integrated National Neglected Tropical Disease Control Program in Mali. PLoS Negl Trop Dis (2012) 1.09
Exploring the influence of the Global Fund and the GAVI Alliance on health systems in conflict-affected countries. Confl Health (2015) 0.99
Global aspirations, local realities: the role of social science research in controlling neglected tropical diseases. Infect Dis Poverty (2014) 0.91
Methods for evaluating the impact of vertical programs on health systems: protocol for a study on the impact of the global polio eradication initiative on strengthening routine immunization and primary health care. BMC Public Health (2012) 0.87
Evaluation of capacity-building program of district health managers in India: a contextualized theoretical framework. Front Public Health (2014) 0.86
Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system. Glob Health Sci Pract (2014) 0.85
The Role of Nurses and Community Health Workers in Confronting Neglected Tropical Diseases in Sub-Saharan Africa: A Systematic Review. PLoS Negl Trop Dis (2016) 0.81
The interface between the national tuberculosis control programme and district hospitals in Cameroon: missed opportunities for strengthening the local health system -a multiple case study. BMC Public Health (2013) 0.81
School-based health education targeting intestinal worms-further support for integrated control. PLoS Negl Trop Dis (2014) 0.80
De-politicizing parasites: reflections on attempts to control the control of neglected tropical diseases. Med Anthropol (2014) 0.78
Ambiguous Capture: Collaborative Capitalism and the Meningitis Vaccine Project. Med Anthropol (2016) 0.75
Extent of Integration of Priority Interventions into General Health Systems: A Case Study of Neglected Tropical Diseases Programme in the Western Region of Ghana. PLoS Negl Trop Dis (2016) 0.75
One year of campaigns in Cameroon: effects on routine health services. Health Policy Plan (2016) 0.75
Integrated Healthcare Delivery: A Qualitative Research Approach to Identifying and Harmonizing Perspectives of Integrated Neglected Tropical Disease Programs. PLoS Negl Trop Dis (2016) 0.75
Overcoming health-systems constraints to achieve the Millennium Development Goals. Lancet (2004) 15.43
Control of neglected tropical diseases. N Engl J Med (2007) 14.49
Financing of global health: tracking development assistance for health from 1990 to 2007. Lancet (2009) 13.41
An assessment of interactions between global health initiatives and country health systems. Lancet (2009) 10.53
Rescuing the bottom billion through control of neglected tropical diseases. Lancet (2009) 6.60
"Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med (2005) 6.33
The effects of global health initiatives on country health systems: a review of the evidence from HIV/AIDS control. Health Policy Plan (2009) 3.44
Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol (2006) 2.87
Global public-private partnerships: Part II--What are the health issues for global governance? Bull World Health Organ (2000) 2.87
A global health fund: a leap of faith? BMJ (2001) 2.70
Critically appraising qualitative research. BMJ (2008) 2.68
Global health actors claim to support health system strengthening: is this reality or rhetoric? PLoS Med (2009) 2.60
Waterborne infectious diseases--could they be consigned to history? Science (2006) 2.48
Donor funding priorities for communicable disease control in the developing world. Health Policy Plan (2006) 2.34
Mass campaigns versus general health services: what have we learnt in 40 years about vertical versus horizontal approaches? Bull World Health Organ (2005) 2.26
Resisting control of neglected tropical diseases: dilemmas in the mass treatment of schistosomiasis and soil-transmitted helminths in north-west Uganda. J Biosoc Sci (2007) 2.21
Qualitative research methodologies: ethnography. BMJ (2008) 2.13
A code of best practice for disease control programmes to avoid damaging health care services in developing countries. Int J Health Plann Manage (2003) 2.01
District health systems in a neoliberal world: a review of five key policy areas. Int J Health Plann Manage (2003) 1.72
Venice statement: global health initiatives and health systems. Lancet (2009) 1.61
What impact do Global Health Initiatives have on human resources for antiretroviral treatment roll-out? A qualitative policy analysis of implementation processes in Zambia. Hum Resour Health (2009) 1.52
Programme activities: a major burden for district health systems? Trop Med Int Health (2008) 1.07
Augmenting frameworks for appraising the practices of community-based health interventions. Health Policy Plan (2009) 0.98
Human schistosomiasis. Lancet (2006) 10.87
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol (2007) 7.36
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis (2002) 7.17
Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clin Infect Dis (2013) 4.03
Strongyloidiasis--the most neglected of the neglected tropical diseases? Trans R Soc Trop Med Hyg (2009) 3.16
A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ (2006) 3.11
Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy. PLoS Negl Trop Dis (2009) 2.56
Control of visceral leishmaniasis in latin america-a systematic review. PLoS Negl Trop Dis (2010) 2.50
Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial. BMJ (2010) 2.30
Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health (2008) 2.28
Spread of vector-borne diseases and neglect of Leishmaniasis, Europe. Emerg Infect Dis (2008) 2.24
Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis (2006) 2.17
Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis (2003) 2.11
Molecular diagnosis of Strongyloides stercoralis in faecal samples using real-time PCR. Trans R Soc Trop Med Hyg (2009) 2.04
Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clin Infect Dis (2012) 2.00
Combination therapy for visceral leishmaniasis. Lancet Infect Dis (2010) 1.96
Integrating tuberculosis and HIV care in the primary care setting in South Africa. Trop Med Int Health (2004) 1.89
The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo. Trop Med Int Health (2004) 1.89
Rapid diagnostic tests for neurological infections in central Africa. Lancet Infect Dis (2013) 1.82
Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru. Clin Infect Dis (2008) 1.73
Multiplex real-time PCR for the detection and quantification of Schistosoma mansoni and S. haematobium infection in stool samples collected in northern Senegal. Trans R Soc Trop Med Hyg (2008) 1.73
Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study. PLoS Negl Trop Dis (2011) 1.67
Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda. J Clin Microbiol (2005) 1.67
Bidirectional introgressive hybridization between a cattle and human schistosome species. PLoS Pathog (2009) 1.65
Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control. PLoS Negl Trop Dis (2011) 1.64
Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence? Trop Med Int Health (2008) 1.63
Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial. PLoS Negl Trop Dis (2010) 1.61
A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin Infect Dis (2012) 1.59
Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment. Trop Med Int Health (2008) 1.59
Trypanosomiasis control, Democratic Republic of Congo, 1993-2003. Emerg Infect Dis (2005) 1.58
Present situation of vector-control management in Bangladesh: a wake up call. Health Policy (2008) 1.54
How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness. J Infect Dis (2010) 1.53
Long-lasting insecticidal nets fail at household level to reduce abundance of sandfly vector Phlebotomus argentipes in treated houses in Bihar (India). Trop Med Int Health (2008) 1.51
A plea for an initiative to strengthen family medicine in public health care services of developing countries. Int J Health Serv (2002) 1.51
Leishmaniases in the Mediterranean in the era of molecular epidemiology. Trends Parasitol (2008) 1.50
Insecticide susceptibility of Phlebotomus argentipes in visceral leishmaniasis endemic districts in India and Nepal. PLoS Negl Trop Dis (2010) 1.50
Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease). PLoS Negl Trop Dis (2010) 1.48
Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors. Trop Med Int Health (2006) 1.43
Challenges in HIV and visceral Leishmania co-infection: future research directions. Trop Med Int Health (2010) 1.41
Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome? Microbes Infect (2007) 1.40
An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia. J Acquir Immune Defic Syndr (2009) 1.40
Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal. Trop Med Int Health (2010) 1.36
The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion (2005) 1.35
Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent. PLoS Negl Trop Dis (2010) 1.35
Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India. Trop Med Int Health (2006) 1.35
High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo. Emerg Infect Dis (2008) 1.33
The epidemiology of Leishmania donovani infection in high transmission foci in India. Trop Med Int Health (2010) 1.30
Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral Leishmaniasis, by using human antibody responses to sand fly saliva. Am J Trop Med Hyg (2010) 1.30
Domestic animals and epidemiology of visceral leishmaniasis, Nepal. Emerg Infect Dis (2010) 1.29
Evaluation of leishmanin skin test in Indian visceral leishmaniasis. Am J Trop Med Hyg (2009) 1.22
Positive spill-over effects of ART scale up on wider health systems development: evidence from Ethiopia and Malawi. J Int AIDS Soc (2011) 1.22
Diagnostic accuracy of a new Leishmania PCR for clinical visceral leishmaniasis in Nepal and its role in diagnosis of disease. Trop Med Int Health (2008) 1.21
Barriers for introducing HIV testing among tuberculosis patients in Jogjakarta, Indonesia: a qualitative study. BMC Public Health (2008) 1.20
Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood. Clin Vaccine Immunol (2012) 1.20
CD4 T-cell count and HIV-1 infection in adults with uncomplicated malaria. J Acquir Immune Defic Syndr (2006) 1.17
Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India. Clin Vaccine Immunol (2010) 1.16
Latent infection with Leishmania donovani in highly endemic villages in Bihar, India. PLoS Negl Trop Dis (2013) 1.16
Double ethical review of North-South collaborative clinical research: hidden paternalism or real partnership? Trop Med Int Health (2011) 1.16
PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar. Trop Med Int Health (2009) 1.16
Phlebotomus argentipes seasonal patterns in India and Nepal. J Med Entomol (2010) 1.14
Voluntary counselling and testing uptake and HIV prevalence among tuberculosis patients in Jogjakarta, Indonesia. Trans R Soc Trop Med Hyg (2008) 1.14
Prevalence and risk factors of intestinal parasites in Cuban children. Trop Med Int Health (2006) 1.13
Human african trypanosomiasis diagnosis in first-line health services of endemic countries, a systematic review. PLoS Negl Trop Dis (2012) 1.13
Population preference of net texture prior to bed net trial in Kala-Azar-endemic areas. PLoS Negl Trop Dis (2007) 1.13
Interferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept study. PLoS Negl Trop Dis (2011) 1.11
Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests. BMC Infect Dis (2013) 1.11
Epidemiology of mixed Schistosoma mansoni and Schistosoma haematobium infections in northern Senegal. Int J Parasitol (2012) 1.10
Bayesian latent class models with conditionally dependent diagnostic tests: a case study. Stat Med (2008) 1.10
Do patents prevent access to drugs for HIV in developing countries? JAMA (2002) 1.09
Low awareness of intestinal schistosomiasis in northern Senegal after 7 years of health education as part of intense control and research activities. Trop Med Int Health (2003) 1.08
Serological markers of sand fly exposure to evaluate insecticidal nets against visceral leishmaniasis in India and Nepal: a cluster-randomized trial. PLoS Negl Trop Dis (2011) 1.08
Programme activities: a major burden for district health systems? Trop Med Int Health (2008) 1.07
Asymptomatic Leishmania infection: a new challenge for Leishmania control. Clin Infect Dis (2014) 1.07
Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010. Indian J Med Res (2012) 1.07
Primary health care vs. emergency medical assistance: a conceptual framework. Health Policy Plan (2002) 1.06
Visceral leishmaniasis in Muzaffarpur district, Bihar, India from 1990 to 2008. PLoS One (2011) 1.06
Field validity, reproducibility and feasibility of diagnostic tests for visceral leishmaniasis in rural Nepal. Trop Med Int Health (2006) 1.04
Human African trypanosomiasis in a rural community, Democratic Republic of Congo. Emerg Infect Dis (2007) 1.04
Therapeutic itineraries of patients with ulcerated forms of Mycobacterium ulcerans (Buruli ulcer) disease in a rural health zone in the Democratic Republic of Congo. Trop Med Int Health (2009) 1.04
[The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense]. Trop Med Int Health (2005) 1.03
Residual activity and integrity of PermaNet® 2.0 after 24 months of household use in a community randomised trial of long lasting insecticidal nets against visceral leishmaniasis in India and Nepal. Trans R Soc Trop Med Hyg (2011) 1.03
Evaluation of latent class analysis and decision thresholds to guide the diagnosis of pediatric tuberculosis in a Rwandan reference hospital. Pediatr Infect Dis J (2010) 1.02
Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DAT/VL). Trop Med Int Health (2006) 1.02
Private practitioners and tuberculosis case detection in Jogjakarta, Indonesia: actual role and potential. Trop Med Int Health (2007) 1.02
T-helper 17 cells are associated with pathology in human schistosomiasis. J Infect Dis (2012) 1.02
Serological markers for leishmania donovani infection in Nepal: Agreement between direct agglutination test and rK39 ELISA. Trop Med Int Health (2010) 1.02
Field evaluation of FD-DAT, rK39 dipstick and KATEX (urine latex agglutination) for diagnosis of visceral leishmaniasis in northwest Ethiopia. Trans R Soc Trop Med Hyg (2007) 1.01
Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000-2010). PLoS Negl Trop Dis (2011) 1.01
Taenia solium cysticercosis in the Democratic Republic of Congo: how does pork trade affect the transmission of the parasite? PLoS Negl Trop Dis (2010) 1.01
Engaging the private sector for tuberculosis control: much advocacy on a meagre evidence base. Trop Med Int Health (2007) 1.00
Neglected tropical disease (NTD) control in health systems: the interface between programmes and general health services. Acta Trop (2011) 0.99
Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo. PLoS Negl Trop Dis (2012) 0.99
Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy. Am J Clin Nutr (2003) 0.99
High prevalence of Taenia solium cysticerosis in a village community of Bas-Congo, Democratic Republic of Congo. Int J Parasitol (2011) 0.99
Comparison of visceral leishmaniasis diagnostic antigens in African and Asian Leishmania donovani reveals extensive diversity and region-specific polymorphisms. PLoS Negl Trop Dis (2013) 0.99